nivolumab,ipilimumab
bms
['nivo', 'ipilimumab', '9la', 'check,mate,9la', 'nivolumab', 'bmsnews', 'bms']
today's newsletter includes an article from : four-year outcomes from phase 3 checkmate-9la trial show durable, long-term survival with nivolumab plus ipilimumab at #asco23 || for more of the top &amp; trending news, visit: #onctwitter #medtwitter 
Your source for the latest in oncology news.